Top compounds associated with response to PRNT


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.027 0.7
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA quizartinib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA avicin D CTRPv2 pan-cancer AAC -0.022 0.7
mRNA canertinib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA PDMP CTRPv2 pan-cancer AAC -0.015 0.7
Download CSV